Katharina Holstein - Concepedia

Author

Katharina Holstein

Also Known As

Andreas Greinacher, G. Marx, H. Pollmann, Holstein Katharina, K Holstein, K. HOLSTEIN, K. Holstein, KATHARINA HOLSTEIN, Katharina Holstein

142

Publications

1.6K

Citations

H-Index

Concepts

All Affiliations

Universität Hamburg University Medical Center Hamburg-Eppendorf Klinikum im Friedrichshain Medizinische Hochschule Hannover Medical University of Vienna

About

Katharina Holstein is an author at Universität Hamburg specializing in medicine, hematology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	343
2	Health Sciences	3	3	140
3	Public Health	1	1	55
4	Allergy	1	1	53
5	Cellular Therapies	1	1	28

Katharina Holstein

Publications

Citations

H-Index

Page 1

	Year	Citations
Prognostic factors for remission of and survival in acquired hemophilia A (AHA): results from the GTH-AH 01/2010 study Andreas Tiede, Robert Klamroth, Rüdiger E. Scharf, Blood	2014	276
Tissue factor procoagulant activity of plasma microparticles in patients with cancer-associated disseminated intravascular coagulation Florian Länger, Brigitte Spath, Katja Haubold, Annals of Hematology ThrombopoiesisThrombosisBlood PlateletPlasma MicroparticlesHematology	2008	90
Anti–factor VIII IgA as a potential marker of poor prognosis in acquired hemophilia A: results from the GTH-AH 01/2010 study Andreas Tiede, Christoph J. Hofbauer, Sonja Werwitzke, Blood	2016	69
Cross‐reacting inhibitors against recombinant porcine factor VIII in acquired hemophilia A: Data from the GTH‐AH 01/2010 Study Halet Türkantoz, Christoph Königs, Paul Knöbl, Journal of Thrombosis and Haemostasis	2019	56
Diagnostic and prognostic value of factor VIII binding antibodies in acquired hemophilia A: data from the GTH‐AH 01/2010 study Sonja Werwitzke, Ulrich Geisen, Ulrike Nowak‐Göttl, Journal of Thrombosis and Haemostasis ImmunohematologyPrognostic ValueImmunologyClinical EpidemiologyPathology	2016	55
Emicizumab prophylaxis in patients with acquired haemophilia A (GTH-AHA-EMI): an open-label, single-arm, multicentre, phase 2 study Andreas Tiede, Christina Hart, Paul Knöbl, The Lancet Haematology AllergyHematologyBleeding DisorderPhase 2Emicizumab Prophylaxis	2023	53
The Relationship Between Prorenin Levels in Follicular Fluid and Follicular Atresia in Bovine Ovaries* Amal K. Mukhopadhyay, Katharina Holstein, Mariusz W. Szkudlinski, Endocrinology	1991	52
Distinct mechanisms account for acquired von Willebrand syndrome in plasma cell dyscrasias Christina Dicke, Sonja Schneppenheim, Katharina Holstein, Annals of Hematology Distinct MechanismsVon Willebrand SyndromeDisease MechanismPathogenesisImmunology	2016	49
Bleeding and Response to Hemostatic Therapy in Acquired Hemophilia A (AHA): Results from the GTH-AH 01/2010 Study Katharina Holstein, Xiaofei Liu, Andrea Smith, Blood	2020	39
Novel, human cell line‐derived recombinant factor VIII (human‐cl rhFVIII; Nuwiq<sup>®</sup>) in adults with severe haemophilia A: efficacy and safety Toshko Lissitchkov, K. K. Hampton, Mario von Depka, Haemophilia	2015	36

Page 1